Skip to main content

CAMBIUM ALERT: Bragar Eagel & Squire, P.C. is Investigating Cambium Networks Corporation on Behalf of Cambium Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cambium Networks Corporation (“Cambium” or the “Company”) (NASDAQ: CMBM) on behalf of Cambium stockholders. Our investigation concerns whether Cambium has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On August 1, 2023, the Company reported its Q2 earnings; Cambium reported quarterly earnings of $0.03 per share, missing Consensus Estimate of $0.21 per share. This compares to earnings of $0.18 per share a year ago. Revenue was $59.5, missing estimates by $17.04M. The Company also announced that CEO Atul Bhatnagar was stepping down immediately.

On this news, Cambium stock fell $0.21 per share, or 2%, to close at $10.37 per share on August 2, 2023.

If you purchased or otherwise acquired Cambium shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.